Vertex Pharmaceuticals Revenue 2010-2023 | VRTX

Vertex Pharmaceuticals annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Vertex Pharmaceuticals revenue for the quarter ending December 31, 2023 was $2.518B, a 9.34% increase year-over-year.
  • Vertex Pharmaceuticals revenue for the twelve months ending December 31, 2023 was $9.869B, a 10.51% increase year-over-year.
  • Vertex Pharmaceuticals annual revenue for 2023 was $9.869B, a 10.51% increase from 2022.
  • Vertex Pharmaceuticals annual revenue for 2022 was $8.931B, a 17.91% increase from 2021.
  • Vertex Pharmaceuticals annual revenue for 2021 was $7.574B, a 22.06% increase from 2020.
Vertex Pharmaceuticals Annual Revenue
(Millions of US $)
2023 $9,869
2022 $8,931
2021 $7,574
2020 $6,206
2019 $4,163
2018 $3,048
2017 $2,489
2016 $1,702
2015 $1,032
2014 $580
2013 $1,212
2012 $1,527
2011 $1,411
2010 $143
2009 $102
Vertex Pharmaceuticals Quarterly Revenue
(Millions of US $)
2023-12-31 $2,518
2023-09-30 $2,484
2023-06-30 $2,493
2023-03-31 $2,375
2022-12-31 $2,303
2022-09-30 $2,334
2022-06-30 $2,196
2022-03-31 $2,098
2021-12-31 $2,073
2021-09-30 $1,984
2021-06-30 $1,793
2021-03-31 $1,724
2020-12-31 $1,628
2020-09-30 $1,538
2020-06-30 $1,524
2020-03-31 $1,515
2019-12-31 $1,413
2019-09-30 $950
2019-06-30 $941
2019-03-31 $858
2018-12-31 $870
2018-09-30 $785
2018-06-30 $752
2018-03-31 $641
2017-12-31 $652
2017-09-30 $578
2017-06-30 $544
2017-03-31 $715
2016-12-31 $459
2016-09-30 $414
2016-06-30 $432
2016-03-31 $398
2015-12-31 $418
2015-09-30 $310
2015-06-30 $166
2015-03-31 $139
2014-12-31 $145
2014-09-30 $179
2014-06-30 $138
2014-03-31 $118
2013-12-31 $351
2013-09-30 $222
2013-06-30 $311
2013-03-31 $328
2012-12-31 $334
2012-09-30 $336
2012-06-30 $418
2012-03-31 $439
2011-12-31 $563
2011-09-30 $659
2011-06-30 $114
2011-03-31 $74
2010-12-31 $66
2010-09-30 $24
2010-06-30 $32
2010-03-31 $22
2009-12-31 $34
2009-09-30 $25
2009-06-30 $19
2009-03-31 $24
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $105.310B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.093B 14.42
Regeneron Pharmaceuticals (REGN) United States $105.862B 25.66
Bristol Myers Squibb (BMY) United States $105.842B 6.98
Gilead Sciences (GILD) United States $91.801B 10.97
CSL (CSLLY) Australia $88.459B 0.00
GSK (GSK) United Kingdom $86.842B 10.96
Moderna (MRNA) United States $39.678B 0.00
Biogen (BIIB) United States $31.879B 14.89
Argenex SE (ARGX) Netherlands $22.018B 0.00
BioNTech SE (BNTX) Germany $21.984B 8.02
Illumina (ILMN) United States $20.296B 146.82
Genmab (GMAB) Denmark $19.783B 25.37
Alnylam Pharmaceuticals (ALNY) United States $18.800B 0.00
BeiGene (BGNE) Cayman Islands $16.235B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.824B 67.10
Incyte (INCY) United States $13.106B 21.78
Karuna Therapeutics (KRTX) United States $12.599B 0.00
Sarepta Therapeutics (SRPT) United States $11.554B 0.00
Bio-Techne Corp (TECH) United States $11.400B 42.41
Repligen (RGEN) United States $10.593B 109.79
Legend Biotech (LEGN) United States $10.568B 0.00
Exact Sciences (EXAS) United States $10.476B 0.00
QIAGEN (QGEN) Netherlands $10.050B 20.80
Bio-Rad Laboratories (BIO.B) United States $9.474B 28.22
Ascendis Pharma (ASND) Denmark $8.581B 0.00
Roivant Sciences (ROIV) United Kingdom $8.171B 0.00
Vaxcyte (PCVX) United States $7.556B 0.00
Exelixis (EXEL) United States $6.967B 35.91
Apellis Pharmaceuticals (APLS) United States $6.842B 0.00
Cytokinetics (CYTK) United States $6.715B 0.00
Viking Therapeutics (VKTX) United States $6.287B 0.00
Intra-Cellular Therapies (ITCI) United States $6.271B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.856B 0.00
Blueprint Medicines (BPMC) United States $5.539B 0.00
Zealand Pharma (ZLDPF) Denmark $5.253B 0.00
Halozyme Therapeutics (HALO) United States $5.191B 16.02
Nuvalent (NUVL) United States $5.177B 0.00
Krystal Biotech (KRYS) United States $4.894B 0.00
Alkermes (ALKS) Ireland $4.803B 25.67
Biohaven (BHVN) United States $4.656B 0.00
Immunovant (IMVT) United States $4.436B 0.00
Apogee Therapeutics (APGE) United States $3.992B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.899B 0.00
Iovance Biotherapeutics (IOVA) United States $3.885B 0.00
Insmed (INSM) United States $3.819B 0.00
Arcellx (ACLX) United States $3.729B 0.00
SpringWorks Therapeutics (SWTX) United States $3.710B 0.00
Axsome Therapeutics (AXSM) United States $3.579B 0.00
Fortrea Holdings (FTRE) United States $3.513B 0.00
ImmunityBio (IBRX) United States $3.425B 0.00
Amicus Therapeutics (FOLD) United States $3.391B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.316B 0.00
IDEAYA Biosciences (IDYA) United States $3.303B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.069B 0.00
Arvinas (ARVN) United States $3.054B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.045B 0.00
Immunocore Holdings (IMCR) United Kingdom $3.031B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.019B 0.00
Certara (CERT) United States $2.951B 63.65
Beam Therapeutics (BEAM) United States $2.892B 0.00
Denali Therapeutics (DNLI) United States $2.801B 0.00
Intellia Therapeutics (NTLA) United States $2.720B 0.00
MorphoSys AG (MOR) Germany $2.687B 0.00
Merus (MRUS) Netherlands $2.541B 0.00
Kymera Therapeutics (KYMR) United States $2.480B 0.00
CG Oncology (CGON) United States $2.445B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.426B 0.00
Keros Therapeutics (KROS) United States $2.423B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.406B 0.00
Neumora Therapeutics (NMRA) United States $2.398B 0.00
Celldex Therapeutics (CLDX) United States $2.348B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.325B 0.00
Vera Therapeutics (VERA) United States $2.271B 0.00
Galapagos (GLPG) Belgium $2.239B 0.00
Guardant Health (GH) United States $2.159B 0.00
Vericel (VCEL) United States $2.137B 0.00
Janux Therapeutics (JANX) United States $2.038B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.998B 0.00
Sana Biotechnology (SANA) United States $1.958B 0.00
Avidity Biosciences (RNA) United States $1.947B 0.00
Twist Bioscience (TWST) United States $1.945B 0.00
Myriad Genetics (MYGN) United States $1.902B 0.00
NeoGenomics (NEO) United States $1.875B 0.00
Bavarian Nordic (BVNRY) Denmark $1.844B 6.05
Geron (GERN) United States $1.835B 0.00
Zai Lab (ZLAB) China $1.826B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.815B 15.09
Morphic Holding (MORF) United States $1.729B 0.00
Arcus Biosciences (RCUS) United States $1.725B 0.00
Kura Oncology (KURA) United States $1.701B 0.00
Protagonist Therapeutics (PTGX) United States $1.689B 0.00
Inhibrx (INBX) United States $1.659B 0.00
Structure Therapeutics (GPCR) United States $1.643B 0.00
Edgewise Therapeutics (EWTX) United States $1.575B 0.00
Dynavax Technologies (DVAX) United States $1.558B 0.00
Akero Therapeutics (AKRO) United States $1.550B 0.00
Disc Medicine (IRON) United States $1.491B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.471B 0.00
Vir Biotechnology (VIR) United States $1.453B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.412B 0.00
Prothena (PRTA) Ireland $1.400B 0.00
ANI Pharmaceuticals (ANIP) United States $1.391B 17.10
AbCellera Biologics (ABCL) Canada $1.379B 0.00
ADMA Biologics Inc (ADMA) United States $1.367B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.352B 0.00
CARGO Therapeutics (CRGX) United States $1.289B 0.00
89BIO (ETNB) United States $1.264B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.260B 0.00
Ligand Pharmaceuticals (LGND) United States $1.259B 15.59
Day One Biopharmaceuticals (DAWN) United States $1.257B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.251B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.248B 0.00
Immunome (IMNM) United States $1.231B 0.00
Kyverna Therapeutics (KYTX) United States $1.213B 0.00
Liquidia Technologies (LQDA) United States $1.209B 0.00
MannKind (MNKD) United States $1.209B 0.00
MiMedx (MDXG) United States $1.158B 262.67
Belite Bio (BLTE) United States $1.121B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.081B 0.00
Viridian Therapeutics (VRDN) United States $1.073B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.070B 0.00
Scholar Rock Holding (SRRK) United States $1.042B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.032B 0.00
Oric Pharmaceuticals (ORIC) United States $1.017B 0.00
Immatics (IMTX) Germany $1.017B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.016B 0.00
REGENXBIO (RGNX) United States $0.986B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.977B 0.00
Tango Therapeutics (TNGX) United States $0.921B 0.00
Pliant Therapeutics (PLRX) United States $0.915B 0.00
Cytek Biosciences (CTKB) United States $0.909B 0.00
Abivax SA (ABVX) France $0.878B 0.00
HilleVax (HLVX) United States $0.872B 0.00
Prime Medicine (PRME) United States $0.859B 0.00
Astria Therapeutics (ATXS) United States $0.849B 0.00
Cabaletta Bio (CABA) United States $0.803B 0.00
WAVE Life Sciences (WVE) Singapore $0.795B 0.00
Allogene Therapeutics (ALLO) United States $0.788B 0.00
Pharming Group (PHGUF) Netherlands $0.783B 0.00
Pharming Group (PHAR) Netherlands $0.771B 0.00
ACELYRIN, INC (SLRN) United States $0.763B 0.00
Zymeworks (ZYME) United States $0.763B 0.00
Tyra Biosciences (TYRA) United States $0.754B 0.00
Fate Therapeutics (FATE) United States $0.743B 0.00
Novavax (NVAX) United States $0.740B 0.00
Aerovate Therapeutics (AVTE) United States $0.739B 0.00
CureVac (CVAC) Germany $0.739B 0.00
EnGene Holdings (ENGN) United States $0.734B 0.00
Cogent Biosciences (COGT) United States $0.733B 0.00
Praxis Precision Medicines (PRAX) United States $0.730B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.714B 0.00
Fulcrum Therapeutics (FULC) United States $0.704B 0.00
PureTech Health (PRTC) United States $0.691B 0.00
Cullinan Oncology (CGEM) United States $0.686B 0.00
Editas Medicine (EDIT) United States $0.665B 0.00
Olema Pharmaceuticals (OLMA) United States $0.646B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.644B 0.00
Nurix Therapeutics (NRIX) United States $0.640B 0.00
Applied Therapeutics (APLT) United States $0.637B 0.00
Biomea Fusion (BMEA) United States $0.637B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.637B 0.00
Northwest Biotherapeutics (NWBO) United States $0.632B 0.00
AnaptysBio (ANAB) United States $0.628B 0.00
IGM Biosciences (IGMS) United States $0.625B 0.00
ArriVent BioPharma (AVBP) United States $0.623B 0.00
C4 Therapeutics (CCCC) United States $0.613B 0.00
Mersana Therapeutics (MRSN) United States $0.611B 0.00
Nkarta (NKTX) United States $0.597B 0.00
Alector (ALEC) United States $0.586B 0.00
Travere Therapeutics (TVTX) United States $0.570B 0.00
GH Research (GHRS) Ireland $0.567B 0.00
ALX Oncology Holdings (ALXO) United States $0.567B 0.00
Replimune (REPL) United States $0.524B 0.00
Mineralys Therapeutics (MLYS) United States $0.522B 0.00
Castle Biosciences (CSTL) United States $0.517B 0.00
Voyager Therapeutics (VYGR) United States $0.504B 3.00
PepGen (PEPG) United States $0.500B 0.00
Nuvation Bio (NUVB) United States $0.497B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.496B 0.00
Caribou Biosciences (CRBU) United States $0.485B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.483B 0.00
Arbutus Biopharma (ABUS) United States $0.470B 0.00
Adaptive Biotechnologies (ADPT) United States $0.470B 0.00
Revance Therapeutics (RVNC) United States $0.468B 0.00
Terns Pharmaceuticals (TERN) United States $0.465B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.461B 0.00
Ventyx Biosciences (VTYX) United States $0.456B 0.00
Absci (ABSI) United States $0.455B 0.00
MaxCyte (MXCT) United States $0.449B 0.00
Celcuity (CELC) United States $0.430B 0.00
Entrada Therapeutics (TRDA) United States $0.429B 0.00
Anavex Life Sciences (AVXL) United States $0.420B 0.00
Dianthus Therapeutics (DNTH) United States $0.416B 0.00
Oculis Holding AG (OCS) Switzerland $0.414B 0.00
Shattuck Labs (STTK) United States $0.414B 0.00
Alto Neuroscience (ANRO) United States $0.404B 0.00
MeiraGTx Holdings (MGTX) United States $0.404B 0.00
Avid Bioservices (CDMO) United States $0.398B 0.00
Invivyd (IVVD) United States $0.396B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.389B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.379B 0.00
Jasper Therapeutics (JSPR) United States $0.378B 0.00
Third Harmonic Bio (THRD) United States $0.377B 0.00
Anika Therapeutics (ANIK) United States $0.372B 0.00
Inozyme Pharma (INZY) United States $0.364B 0.00
Annexon (ANNX) United States $0.356B 0.00
Precigen (PGEN) United States $0.356B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
Adverum Biotechnologies (ADVM) United States $0.352B 0.00
AC Immune (ACIU) Switzerland $0.347B 0.00
TScan Therapeutics (TCRX) United States $0.341B 0.00
Urogen Pharma (URGN) United States $0.339B 0.00
Tenaya Therapeutics (TNYA) United States $0.339B 0.00
Atea Pharmaceuticals (AVIR) United States $0.338B 0.00
Humacyte (HUMA) United States $0.336B 0.00
Adlai Nortye (ANL) Cayman Islands $0.332B 0.00
Gossamer Bio (GOSS) United States $0.329B 0.00
FibroBiologics (FBLG) United States $0.328B 0.00
Erasca (ERAS) United States $0.323B 0.00
Kamada (KMDA) Israel $0.322B 24.35
Monte Rosa Therapeutics (GLUE) United States $0.321B 0.00
Nautilus Biotechnology (NAUT) United States $0.320B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.312B 0.00
Poseida Therapeutics (PSTX) United States $0.311B 0.00
Kodiak Sciences (KOD) United States $0.307B 0.00
XOMA (XOMA) United States $0.306B 0.00
Rapt Therapeutics (RAPT) United States $0.295B 0.00
Compass Therapeutics (CMPX) United States $0.292B 0.00
Stoke Therapeutics (STOK) United States $0.285B 0.00
Verastem (VSTM) United States $0.278B 0.00
Ocugen (OCGN) United States $0.277B 0.00
Aura Biosciences (AURA) United States $0.275B 0.00
Solid Biosciences (SLDB) United States $0.264B 0.00
Werewolf Therapeutics (HOWL) United States $0.262B 0.00
Inovio Pharmaceuticals (INO) United States $0.251B 0.00
Sutro Biopharma (STRO) United States $0.251B 0.00
UniQure (QURE) Netherlands $0.247B 0.00
Coherus BioSciences (CHRS) United States $0.247B 0.00
Mesoblast (MESO) Australia $0.247B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.242B 0.00
Akoya Biosciences (AKYA) United States $0.241B 0.00
Puma Biotechnology (PBYI) United States $0.241B 10.87
Compugen (CGEN) Israel $0.236B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.235B 0.00
Codexis (CDXS) United States $0.234B 0.00
Gritstone Bio (GRTS) United States $0.233B 0.00
Scilex Holding (SCLX) United States $0.228B 0.00
Agenus (AGEN) United States $0.226B 0.00
Greenwich LifeSciences (GLSI) United States $0.225B 0.00
Cardiff Oncology (CRDF) United States $0.225B 0.00
Lifecore Biomedical (LFCR) United States $0.224B 0.00
Repare Therapeutics (RPTX) Canada $0.223B 0.00
Alimera Sciences (ALIM) United States $0.220B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.219B 76.20
Inventiva S.A (IVA) France $0.219B 0.00
23andMe Holding (ME) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Trevi Therapeutics (TRVI) United States $0.214B 0.00
Abeona Therapeutics (ABEO) United States $0.214B 0.00
Elevation Oncology (ELEV) United States $0.214B 0.00
Renovaro (RENB) United States $0.211B 0.00
ScPharmaceuticals (SCPH) United States $0.210B 0.00
Prima BioMed (IMMP) Australia $0.210B 0.00
CorMedix Inc (CRMD) United States $0.209B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.208B 0.00
2seventy Bio (TSVT) United States $0.206B 0.00
Innate Pharma S.A (IPHA) France $0.204B 0.00
Opthea (OPT) Australia $0.201B 0.00
Omega Therapeutics (OMGA) United States $0.200B 0.00
INmune Bio (INMB) United States $0.199B 0.00
Nuvectis Pharma (NVCT) United States $0.195B 0.00
Graphite Bio (GRPH) United States $0.195B 0.00
Ovid Therapeutics (OVID) United States $0.192B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.184B 0.00
Spyre Therapeutics (SYRE) United States $0.184B 0.00
ChromaDex (CDXC) United States $0.181B 0.00
XBiotech (XBIT) United States $0.180B 0.00
GENFIT S.A (GNFT) France $0.175B 0.00
Genelux (GNLX) United States $0.167B 0.00
Adocia (ADOCY) France $0.166B 0.00
Rani Therapeutics Holdings (RANI) United States $0.166B 0.00
G1 Therapeutics (GTHX) United States $0.162B 0.00
Bluebird Bio (BLUE) United States $0.155B 0.00
X4 Pharmaceuticals (XFOR) United States $0.155B 0.00
PDS Biotechnology (PDSB) United States $0.152B 0.00
DBV Technologies S.A (DBVT) France $0.152B 0.00
I-Mab (IMAB) China $0.150B 0.00
Design Therapeutics (DSGN) United States $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Cellectis S.A (CLLS) France $0.141B 0.00
Ocean Biomedical (OCEA) United States $0.140B 0.00
Adicet Bio (ACET) United States $0.140B 0.00
CytomX Therapeutics (CTMX) United States $0.140B 0.00
Sangamo Therapeutics (SGMO) United States $0.140B 0.00
Zura Bio (ZURA) United States $0.137B 0.00
ATyr Pharma (LIFE) United States $0.135B 0.00
NGM Biopharmaceuticals (NGM) United States $0.131B 0.00
Vor Biopharma (VOR) $0.131B 0.00
TELA Bio (TELA) United States $0.131B 0.00
Seer (SEER) United States $0.128B 0.00
Emergent Biosolutions (EBS) United States $0.128B 0.00
Clearside Biomedical (CLSD) United States $0.128B 0.00
Syros Pharmaceuticals (SYRS) United States $0.127B 0.00
Adagene (ADAG) China $0.126B 0.00
Genetron Holdings (GTH) China $0.123B 0.00
Kinnate Biopharma (KNTE) United States $0.121B 0.00
Vigil Neuroscience (VIGL) United States $0.120B 0.00
Vincerx Pharma (VINC) United States $0.119B 0.00
Seres Therapeutics (MCRB) United States $0.119B 0.00
Immunic (IMUX) United States $0.118B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.118B 0.00
BioAtla (BCAB) United States $0.117B 0.00
Alpha Teknova (TKNO) United States $0.116B 0.00
Allakos (ALLK) United States $0.115B 0.00
DiaMedica Therapeutics (DMAC) United States $0.115B 0.00
BeyondSpring (BYSI) United States $0.114B 0.00
Celularity (CELU) United States $0.110B 0.00
VistaGen Therapeutics (VTGN) United States $0.109B 0.00
IO Biotech (IOBT) Denmark $0.109B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
CervoMed (CRVO) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
BioHarvest Sciences (CNVCF) Canada $0.101B 0.00
Athira Pharma (ATHA) United States $0.100B 0.00
Eton Pharmaceuticals (ETON) United States $0.099B 0.00
Semper Paratus Acquisition (TVGN) United States $0.098B 0.00
Spero Therapeutics (SPRO) United States $0.096B 3.58
Annovis Bio (ANVS) United States $0.096B 0.00
Vaxxinity (VAXX) United States $0.096B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.095B 0.00
Cartesian Therapeutics (RNAC) United States $0.094B 0.00
Cue Biopharma (CUE) United States $0.093B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.093B 0.00
Lantern Pharma (LTRN) United States $0.093B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.091B 0.00
AN2 Therapeutics (ANTX) United States $0.089B 0.00
Equillium (EQ) United States $0.089B 0.00
Neurogene (NGNE) United States $0.088B 0.00
Sagimet Biosciences (SGMT) United States $0.086B 0.00
Passage Bio (PASG) United States $0.083B 0.00
BioXcel Therapeutics (BTAI) United States $0.081B 0.00
Instil Bio (TIL) United States $0.081B 0.00
Elutia (ELUT) United States $0.080B 0.00
Turnstone Biologics (TSBX) United States $0.077B 0.00
Ikena Oncology (IKNA) United States $0.076B 0.00
Oncolytics Biotech (ONCY) Canada $0.075B 0.00
Connect Biopharma Holdings (CNTB) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Cognition Therapeutics (CGTX) United States $0.071B 0.00
InflaRx (IFRX) Germany $0.071B 0.00
Rezolute (RZLT) United States $0.071B 0.00
Eyenovia (EYEN) United States $0.070B 0.00
Aligos Therapeutics (ALGS) United States $0.069B 0.00
Affimed (AFMD) Germany $0.068B 0.00
Kronos Bio (KRON) United States $0.068B 0.00
YS Biopharma (YS) China $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.066B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.065B 0.00
Kezar Life Sciences (KZR) United States $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Atara Biotherapeutics (ATRA) United States $0.063B 0.00
Cidara Therapeutics (CDTX) United States $0.062B 0.00
Enzo Biochem (ENZ) United States $0.062B 0.00
Rallybio (RLYB) United States $0.061B 0.00
Curis (CRIS) United States $0.061B 0.00
HOOKIPA Pharma (HOOK) United States $0.060B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.060B 0.00
AVROBIO (AVRO) United States $0.058B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.057B 0.00
Leap Therapeutics (LPTX) United States $0.057B 0.00
Immuneering (IMRX) United States $0.056B 0.00
Beyond Air (XAIR) United States $0.056B 0.00
Bionano Genomics (BNGO) United States $0.055B 0.00
HCW Biologics (HCWB) United States $0.055B 0.00
Aadi Bioscience (AADI) United States $0.053B 0.00
Immix Biopharma (IMMX) United States $0.052B 0.00
Apollomics (APLM) Taiwan $0.052B 0.00
Clene (CLNN) United States $0.051B 0.00
Quince Therapeutics (QNCX) United States $0.050B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.049B 0.00
Lexaria Bioscience (LEXX) Canada $0.048B 0.00
Cara Therapeutics (CARA) United States $0.048B 0.00
BRIACELL THERAP (BCTX) Canada $0.047B 0.00
Ocuphire Pharma (OCUP) United States $0.047B 0.00
Carmell (CTCX) United States $0.047B 0.00
VTv Therapeutics (VTVT) United States $0.047B 0.00
Dare Bioscience (DARE) United States $0.046B 0.00
Precision BioSciences (DTIL) United States $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.045B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.045B 0.00
Candel Therapeutics (CADL) United States $0.043B 0.00
Dyadic (DYAI) United States $0.043B 0.00
NKGen Biotech (NKGN) United States $0.043B 0.00
Prenetics Global (PRE) Cayman Islands $0.043B 52.04
OKYO Pharma (OKYO) $0.043B 0.00
Gyre Therapeutics (GYRE) United States $0.042B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
Elicio Therapeutics (ELTX) United States $0.042B 0.00
Pluri (PLUR) Israel $0.041B 0.00
Femasys (FEMY) United States $0.041B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
NextCure (NXTC) United States $0.040B 0.00
Entera Bio (ENTX) Israel $0.039B 0.00
LianBio (LIAN) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.038B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.037B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.037B 0.00
IN8bio (INAB) United States $0.036B 0.00
Promis Neurosciences (PMN) Canada $0.036B 0.00
Galena Biopharma (SLS) United States $0.035B 0.00
Evogene (EVGN) Israel $0.034B 0.00
Gamida Cell (GMDA) United States $0.034B 0.00
Spruce Biosciences (SPRB) United States $0.033B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Theratechnologies (THTX) Canada $0.030B 0.00
Biora Therapeutics (BIOR) United States $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.027B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Orgenesis (ORGS) United States $0.025B 0.00
ARCA Biopharma (ABIO) United States $0.025B 0.00
Aptose Biosciences (APTO) Canada $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Aprea Therapeutics (APRE) United States $0.023B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
CalciMedica (CALC) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Galecto (GLTO) Denmark $0.022B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
Landos Biopharma (LABP) United States $0.021B 0.00
KALA BIO (KALA) United States $0.020B 0.00
Xilio Therapeutics (XLO) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.019B 0.00
Purple Biotech (PPBT) Israel $0.018B 0.00
NuCana (NCNA) United Kingdom $0.018B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.017B 0.00
TFF Pharmaceuticals (TFFP) United States $0.017B 0.00
Fortress Biotech (FBIO) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.017B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
Moleculin Biotech (MBRX) United States $0.017B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Telesis Bio (TBIO) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Acorda Therapeutics (ACOR) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Seelos Therapeutics (SEEL) United States $0.014B 0.00
VBI Vaccines (VBIV) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.013B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Evaxion Biotech (EVAX) Denmark $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Psyence Biomedical (PBM) United States $0.011B 0.00
Longeveron (LGVN) United States $0.011B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.011B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Trevena (TRVN) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.010B 0.00
Portage Biotech (PRTG) $0.010B 0.00
Monopar Therapeutics (MNPR) United States $0.010B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Imunon (IMNN) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Prana Biotechnology (ATHE) Australia $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Atreca (BCEL) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Soligenix (SNGX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Biorestorative Therapies (BRTX) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
NexImmune (NEXI) United States $0.006B 0.00
Virios Therapeutics (VIRI) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Exicure (XCUR) United States $0.006B 0.39
Kineta (KA) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Atrinsic (PTIX) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Kintara Therapeutics (KTRA) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
NeuBase Therapeutics (NBSE) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Sunshine Biopharma (SBFM) Canada $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Tenax Therapeutics (TENX) United States $0.001B 0.00
Cingulate (CING) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00